Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide-drug conjugates: A new paradigm for targeted cancer therapy
Mo Wang, Jiawei Liu, Mingjing Xia, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116119-116119
Closed Access | Times Cited: 22

Showing 22 citing articles:

Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989
Othman Al Musaimi
Cancers (2024) Vol. 16, Iss. 5, pp. 1032-1032
Open Access | Times Cited: 10
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
Syed Faheem Askari Rizvi, Haixia Zhang, Quan Fang
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2420-2471
Closed Access | Times Cited: 6
Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
Yangyang Gao, Yuwei Xia, Yixin Chen, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Synthesis and Investigation of Peptide–Drug Conjugates Comprising Camptothecin and a Human Protein‐Derived Cell‐Penetrating Peptide
Isabella R. Palombi, Andrew M. White, Yasuko Koda, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 1
Open Access
Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications
Qimeng Yang, Zhipeng Hu, Hongyu Jiang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 31-42
Closed Access
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives
Patrick G. Minges, Matthias Eder, Ann-Christin Eder
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 143-143
Open Access
Bioorthogonal reaction-mediated photosensitizer–peptide conjugate anchoring on cell membranes for enhanced photodynamic therapy
Buwei Hu, Chenlin Ji, Zhimin Zhou, et al.
Biomaterials Science (2025)
Closed Access
A peptide-based fluorescent bioprobe for EphA2-overexpressing tumor targeting and image-guided surgical resection
Xudong Yu, Jian Jin, Yu Si, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118090-118090
Closed Access
Natural-source payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions
Cuiping Li, Kourong Shi, Siyuan Zhao, et al.
Pharmacological Research (2024) Vol. 207, pp. 107341-107341
Open Access | Times Cited: 5
New Transferrin Receptor-Targeted Peptide–Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity
Jiale Yu, Xiaoxia Mao, Xue Yang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 2
Design and synthesis of TH19P01-Camptothecin based hybrid peptides inducing effective anticancer responses on sortilin positive cancer cells
Yajie Li, Chang-Bo Fang, Shu‐shu Wang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 111, pp. 117869-117869
Closed Access | Times Cited: 2
Zilucoplan: A Newly Approved Macrocyclic Peptide for Treatment of Anti-Acetylcholine Receptor Positive Myasthenia Gravis
Lia Costa, Carla Fernandes
Drugs and Drug Candidates (2024) Vol. 3, Iss. 2, pp. 311-327
Open Access | Times Cited: 1
LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer
Bo Wu, Xin Huang, Xiang Shi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Strategies for Targeting Peptide-Modified Exosomes and Their Applications in the Lungs
Min Qiu, Jinru Zou, Yang Zheng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8175-8188
Open Access
Advancing Ovarian Cancer Therapeutics: The Role of Targeted Drug Delivery Systems
Qianhan Lin, Jiajia Li, Zulimire Abudousalamu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9351-9370
Open Access
Design and Synthesis of Luteinizing Hormone Releasing Hormone (Lhrh)-Derived Peptide Conjugates with Pi3k Inhibitor for Enhanced Tumor Selectivity
Chenyu Zhang, Zhong Hong-lan, Xiang Li, et al.
(2024)
Closed Access
Emerging roles of long non-coding RNA FOXP4-AS1 in human cancers: From Molecular Biology to Clinical Application
Jingjie Yang
Heliyon (2024) Vol. 10, Iss. 21, pp. e39857-e39857
Open Access
M2pep-Tasquinimod Ameliorates Chronic Pancreatitis Via Targeted Inhibition of M2-Like Macrophage Polarization
Xin Kong, Xufeng Tao, Hong Xiang, et al.
(2024)
Closed Access
Navigating cancer therapy: Harnessing the power of peptide-drug conjugates as precision delivery vehicles
Bulbul Sagar, Sarthak Gupta, Mukesh Kumar, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117131-117131
Closed Access
Novel Cyclic Peptide–Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer
Andrii Bazylevich, Anthony R. Miller, Irina G. Tkachenko, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1613-1613
Open Access
Pentagalloyl Glucose from Bouea macrophylla Suppresses the Epithelial–Mesenchymal Transition and Synergizes the Doxorubicin-Induced Anticancer and Anti-Migration Effects in Triple-Negative Breast Cancer
Jiraporn Kantapan, Phattarawadee Innuan, Sarawut Kongkarnka, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1729-1729
Open Access
Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
Xinyang Shen, Yuan Ma, Hang Luo, et al.
Pharmaceutics (2024) Vol. 17, Iss. 1, pp. 40-40
Open Access
Page 1

Scroll to top